Takeda Pharmaceutical (TAK) Change in Taxes (2018 - 2026)

Takeda Pharmaceutical has reported Change in Taxes for 9 years, with the latest figure at -$106.0 million in Q2 2026.

• On a quarterly basis, Change in Taxes rose 58.14% year-over-year to -$106.0 million in Q2 2026; TTM through Jun 2026 was -$1.5 billion, a 31.61% decrease from a year earlier, with the FY2026 full-year figure at -$1.2 billion, down 2.72% from the prior year.
• Change in Taxes was -$106.0 million for Q2 2026 at Takeda Pharmaceutical, up from -$411.1 million in the prior quarter.
• The five-year high for Change in Taxes was -$106.0 million in Q2 2026, with the low at -$1.3 billion in Q3 2022.
• Average Change in Taxes over 5 years is -$431.0 million, with a median of -$341.9 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Taxes tumbled 222.89% in 2022, then soared 72.32% in 2024.
• Over 5 years, Change in Taxes stood at -$410.1 million in 2022, then rose by 17.08% to -$340.0 million in 2023, then soared by 39.51% to -$205.7 million in 2024, then advanced by 24.06% to -$156.2 million in 2025, then surged by 32.12% to -$106.0 million in 2026.
• The last three Change in Taxes figures came in at -$106.0 million (Q2 2026), -$411.1 million (Q1 2026), and -$156.2 million (Q4 2025), per Business Quant data.